Landmark study sheds new light on the heterogeneity of type 2 diabetes

FHS
May 13, 2024
5:12 pm

A landmark study by the DZD, published in ‘The Lancet Diabetes & Endocrinology’, sheds new light on the heterogeneity of type 2 diabetes.

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of

September 9, 2023

Patient experience in the spotlight at Clinical Trials in Oncology Europe 2024

The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI to business

November 16, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 – Biotech Investments

Rancho Cucamonga, 11/06/2024 / 13:06, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Reports Net Revenues of $191.2 Million for the Three Months Ended September

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.